Instrumentation Laboratory Company, a prominent player in the medical diagnostics industry, is headquartered in the United States. Founded in 1959, the company has established itself as a leader in the development of innovative solutions for critical care and laboratory diagnostics. With a strong presence in North America and Europe, Instrumentation Laboratory focuses on providing advanced haemostasis, blood gas, and electrolyte analysis systems. The company’s core products, including the ACL TOP® series and GEM® Premier analysers, are renowned for their precision and reliability, setting them apart in a competitive market. Instrumentation Laboratory's commitment to quality and innovation has earned it a respected position within the industry, marked by numerous accolades and a loyal customer base. As a subsidiary of Werfen, the company continues to drive advancements in diagnostic technology, enhancing patient care worldwide.
How does Instrumentation Laboratory Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Instrumentation Laboratory Company's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Instrumentation Laboratory Company, headquartered in the US, currently does not have specific carbon emissions data available for reporting. As a current subsidiary of Werfen, S.A., any emissions data would be inherited from this parent company. However, there are no documented reduction targets or climate pledges outlined for Instrumentation Laboratory Company at this time. The absence of specific emissions figures and reduction initiatives suggests that the company may still be in the early stages of formalising its climate commitments. In the broader context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. As Instrumentation Laboratory Company continues to align with its parent company's sustainability goals, it may eventually establish its own targets and reporting mechanisms to contribute to global climate efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 3,271,000 |
| Scope 2 | 1,354,000 |
| Scope 3 | 85,403,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Instrumentation Laboratory Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
